REVRAMP

  • Research type

    Research Study

  • Full title

    Reverse RAMP pacing to terminate ventricular tachycardia ( REV-RAMP)

  • IRAS ID

    224714

  • Contact name

    Muzahir Tayebjee

  • Contact email

    muzahir.tayebjee@nhs.net

  • Sponsor organisation

    LTHT

  • Duration of Study in the UK

    2 years, 1 months, 31 days

  • Research summary

    Cardiac pacing which involved stimulating the heart electrically with electrical wires that go into the heart is routine practice in the diagnosis and treatment of heart rhythm problems. Clinically this involved the fields of cardiac pacing and electrophysiology.
    Patients who are at risk of sudden death because of serious heart rhythms that are a result of malfunction of the electrical system of the pumping chambers of the heart (ventricles) are generally implanted with specialised pacemakers that can defibrillate (shock) the heart if a nasty life threatening rhythm should result. Shocks are painful and in order to try and treat these rhythms without shocks, anti tachycardia pacing is performed (this is routine part of the device), which aims to interrupt the rhythm by stimulating the heart electrically. This does not always work and can destabilise the rhythm leading to a shock. REVRAMP is a novel modification of anti tachycardia pacing which involved stimulating the heart through the defibrillator wires in a different way. We want to determine whether this novel protocol works better than current
    methods of antitachycardia pacing and is less likely to cause unstable rhythms.

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    17/EM/0206

  • Date of REC Opinion

    1 Aug 2017

  • REC opinion

    Further Information Favourable Opinion